Clinical Trials
14 trialsNCT04504331 2026-02-12
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford University
Phase 1 Terminated
NCT03053960 2025-04-30
Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
Thomas Jefferson University
Terminated
NCT03824535 2025-04-09
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Stanford University
Phase 2 Completed
NCT02695628 2024-01-31
[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer
Stanford University
Phase 2 Completed
NCT03089606 2023-11-15
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT00584233 2022-12-06
Evaluation of Breast CT
University of California, Davis
Phase NA Completed
NCT02130427 2022-07-22
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03125629 2021-04-09
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Stanford University
Phase 2 Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02663817 2020-02-05
DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy
University of Miami
Phase NA Completed
NCT02084147 2019-10-29
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Case Comprehensive Cancer Center
Phase NA Completed
NCT02388932 2019-01-24
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
Case Comprehensive Cancer Center
Phase NA Terminated
NCT01395030 2018-09-26
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
Queen's Medical Center
Phase 2 Completed
NCT02236546 2017-04-13
FDG-PET in Advanced Melanoma
Vanderbilt-Ingram Cancer Center
Phase NA Terminated